Header image

Session G: Monitoring HCV elimination among PWID (EMCDDA sponsored session)

Tracks
.
Wednesday, September 19, 2018
4:15 PM - 5:45 PM
Sala II

Speaker

Mr Thomas Seyler
Analyst
EMCDDA

Monitoring the elimination of HCV as a public health threat among PWID in the EU

4:15 PM - 4:30 PM

Video Recording

Biography

Dr Hannah Fraser
Senior Research Associate In Infectious Disease Mathematical Modelling
University Of Bristol

Model projections of the impact of HCV treatment on chronic HCV in European settings

4:30 PM - 4:45 PM

Biography

MD PhD Esther Croes
Senior Research Associate
Trimbos Institute

HCV elimination in Dutch PWUD? The 5 steps of the national hepatitis plan

4:45 PM - 5:00 PM

Video Recording

Biography

Professor, Md, Phd Mojca Maticic
Head Of Hepatitis Department
Clinic For Infectious Diseases And Febrile Illnesses, Univesity Medical Centre Ljubljana, Slovenia

Towards HCV elimination in PWID in Slovenia: how to monitor a real-life situation?

5:00 PM - 5:15 PM

Biography

Dr Ruth Zimmermann
Senior Epidemiologist
Robert Koch Institute

Progress and Challenges in Monitoring Elimination Among People who Inject Drugs

5:15 PM - 5:20 PM

Speaker Presentation

Video Recording

Biography

Questions & Discussion

Questions & Discussion

5:20 PM - 5:45 PM

Biography

Chair

Antons Mozalevskis
Medical Officer
WHO Regional Office For Europe

Footer image
loading